Related Experiment Video
Updated: May 30, 2026

08:44
Dried Blood and Serum Spots As A Useful Tool for Sample Storage to Evaluate Cancer Biomarkers
Published on: June 11, 2018
Dried blood spots: a new tool for tuberculosis treatment optimization
D H Vu1, J W C Alffenaar, P M Edelbroek
1Department of Pharmacotherapy and Pharmaceutical Care, University of Groningen, The Netherlands.
Current Pharmaceutical Design
|August 13, 2011
Summary
Dried blood spot sampling simplifies tuberculosis therapeutic drug monitoring, overcoming logistical barriers and enabling remote patient care. This method is ideal for high-burden areas and pediatric TB cases.
Area of Science:
- Pharmacology and Infectious Diseases
- Clinical Chemistry and Diagnostics
Background:
- Tuberculosis (TB) remains a significant global health challenge, exacerbated by multidrug resistance and TB-HIV coinfection.
- Therapeutic drug monitoring (TDM) for anti-TB agents is increasingly recognized but hindered by conventional blood sampling logistics.
- High TB prevalence often overlaps with high HIV prevalence, posing unique challenges for patient management.
Purpose of the Study:
- To evaluate Dried Blood Spot (DBS) sampling as a viable alternative to conventional venous blood sampling for TDM in TB patients.
- To highlight the advantages of DBS in overcoming logistical challenges and facilitating TDM in resource-limited and remote settings.
- To address the specific benefits of DBS for pediatric TB and in co-infected populations.
Main Methods:
- Comparison of DBS sampling with conventional venous blood sampling for pharmacokinetic/pharmacodynamic analysis of anti-TB drugs.
- Assessment of DBS advantages including ease of collection, storage, transportation, and reduced biohazardous risk.
- Consideration of factors influencing DBS analysis method development, validation, and agreement with plasma/serum concentrations.
Main Results:
- DBS sampling offers significant logistical advantages over conventional methods, enabling TDM in remote areas.
- DBS is suitable for high HIV prevalence settings due to lower biohazardous risk and smaller blood volume requirements.
- DBS is particularly beneficial for pediatric TB and requires careful method development for accurate analysis.
Conclusions:
- Dried Blood Spot sampling presents a practical and advantageous approach for therapeutic drug monitoring in tuberculosis management.
- The adoption of DBS can expand TDM accessibility, especially in resource-limited settings and for vulnerable populations like pediatric TB patients.
- Further research is needed to optimize DBS analysis methods and fully understand its correlation with plasma/serum drug concentrations.
Related Concept Videos
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:

